Skip to content
orbyd

Dossier · BHE · Dormant

BHE · Benchmark Electronics · Stock research

MEDIUM Cyclical recovery Catalyst · cyclical-industrials ai-datacenter-infrastructure physical-ai-robotics semi-foundry-equipment

Last analysed ·

Current thesis

EMS arms-dealer to two secular ramps at once AI datacenter liquid-cooling (AC&C +41% YoY, Q1 CY2026) and the 2026-06-15 Ouster Rev8 lidar expansion (>100k units/yr, 10-yr life). Narrative accelerating, but the tape sits ~18% above the $78 avg PT in a catalyst vacuum narrowing toward the 2026-08-05 Q2 print.

Invalidation trigger

A weekly close below $84 loses the $88–89 breakout pivot that should now act as support and marks a failed breakout; a secondary break comes if Q2 CY2026 revenue prints below the $700M guide floor on the 2026-08-05 report.

Thesis status

Open commitment catalyst in 17dscored if the trigger above fires How this is scored →

Latest analysis and events for BHE —

As of 2026-06-15, orbyd's latest analysis for Benchmark Electronics (BHE): Ouster + Benchmark expanded partnership to scale HIGH-VOLUME production of new Rev8 digital-lidar OS sensor family. Benchmark does complex microelectronics + automated optical assembly across 20 facilities/8 countries; capacity >100,000 units/yr; planned 10-year production life; markets = industrial/robotics/automotive/smart-infra. No financial terms disclosed. This is a SECOND secular leg (autonomy/robotics) on top of AI-cooling.

Invalidation trigger: A weekly close below $84 loses the $88–89 breakout pivot that should now act as support and marks a failed breakout; a secondary break comes if Q2 CY2026 revenue prints below the $700M guide floor on the 2026-08-05 report.

Next dated event on file: — catalyst in 17d.

Current Thesis

Benchmark is a legacy electronics-manufacturing-services (EMS) contract builder that has re-rated into a supplier levered to two secular ramps simultaneously. The first leg is AI datacenter thermal: Advanced Computing & Communications (AC&C) revenue grew +41% YoY in Q1 CY2026 (reported 2026-04-29) on liquid- and water-cooling program wins for HPC and AI clusters, and management lifted FY26 revenue-growth guidance to 9–10% from prior mid-single-digit. The second leg arrived 2026-06-15: Benchmark scales Ouster's Rev8 digital-lidar family to more than 100,000 units per year across 20 facilities in 8 countries on a planned 10-year production life, adding an autonomy/robotics-sensing revenue stream on top of the cooling business. The narrative is accelerating; the friction is timing. After the 2026-06-15 announcement the stock printed a fresh all-time high near $94.75, and around ~$92 it trades roughly 18% above the $78 average analyst price target, with the next hard company catalyst the Q2 CY2026 print not due until 2026-08-05.

Bullish and bearish views on Benchmark Electronics

The model's bull view on Benchmark Electronics (BHE), in brief: Ouster Rev8 production expansion (2026-06-15): capacity of >100,000 units/year on a 10-year production life across 20 facilities/8 countries, a multi-year autonomy-sensing leg layered onto the cooling ramp. The bear view: At ~$92 the price sits ~18% above the $78 average PT (high $92, low $62); Simply Wall St pegs estimated fair value near $60, putting the stock 50%+ above that mark. Both cases follow in full.

Bull Case

  • Ouster Rev8 production expansion (2026-06-15): capacity of >100,000 units/year on a 10-year production life across 20 facilities/8 countries, a multi-year autonomy-sensing leg layered onto the cooling ramp. No financial terms were disclosed, but decade-length commitments are structural rather than spot.
  • AC&C +41% YoY (Q1 CY2026, reported 2026-04-29) driven by water-cooling programs for HPC/AI datacenters; Benchmark was named HPE Supplier of the Year.
  • FY26 revenue-growth guide raised to 9–10% (from mid-single-digit) on the 2026-04-29 call, with operating income and EPS guided to grow faster than revenue.
  • Q2 CY2026 guide of $700–740M revenue / $0.65–0.71 non-GAAP EPS (issued 2026-04-29) implies ~+12% YoY at the midpoint off the $677.3M Q1 base.
  • Q1 CY2026 operating profit +86% YoY, net income +257% YoY, operating cash flow $47M (+49%), FCF ~$29M, cash-conversion cycle 67 days from 86 the ramp is internally funded.
  • Datacenter liquid-cooling TAM modeled at $6B (2026) rising toward $27B (2035), ~18% CAGR (Omdia/GMI); Ecolab's CoolIT acquisition signals strategic-buyer interest in the same theme.

Bear Case

  • At ~$92 the price sits ~18% above the $78 average PT (high $92, low $62); Simply Wall St pegs estimated fair value near $60, putting the stock 50%+ above that mark. The asymmetric entry zone was the $40–50 area earlier in the run, not at the all-time high.
  • Insider selling was flagged across the prior three months (as of 2026-06-15) into a rising tape the people closest to the business distributing into strength.
  • Thin EMS economics: net margin ~1.3% (down from ~1.9% YoY), Q1 gross margin ~10.2%. A single program loss or a hyperscaler capex air-pocket compresses AC&C quickly.
  • Catalyst vacuum: with the Ouster news already priced, there is no dated company catalyst between now and the 2026-08-05 Q2 print. An extended tape with nothing to feed it tends to drift or consolidate.
  • Valuation is rich on trailing numbers TTM P/E ~89 (forward ~29 on the guided ramp) so the multiple depends on the ramp continuing to compound.

Setup & Price Structure

The anticipated mean-reversion to the 20-week EMA (~$72) never came. Instead BHE based above its prior $88–89 ceiling and broke to a fresh high near $94.75 on the 2026-06-15 Ouster catalyst; the failed push and −5.2% distribution day on 2026-06-05 (rejection near $88.5 off the $89.40 52-week high) consolidated rather than rolled over. YTD the stock is up roughly +105%, with a 52-week range of $34.44–$94.75 and market cap near $3.0B on ~35.9M shares. The read now is an accelerating narrative sitting on an extended chart: price is well above the Street's average target and stretched versus its moving averages, with the $88–89 zone the first shelf that should hold on any pullback. Chasing the all-time high here carries poor near-term risk/reward; a retest of the $88–89 breakout shelf, or a deeper reset toward the ~$72 20-week EMA, would offer a cleaner base to work against and with the print now inside a month, the window for a fresh position without earnings risk is narrowing.

Catalyst Calendar (next 30 days)

  • ~2026-07-31 (est.): start of the 3-trading-day pre-earnings window ahead of the Q2 print fresh sizing into that window carries binary risk.
  • 2026-08-05: Q2 CY2026 earnings print (25 days out). Guide is $700–740M revenue / $0.65–0.71 non-GAAP EPS; the AC&C and Ouster acceleration story is confirmed or broken here.

Elapsed catalysts

  • Ongoing (no dated milestone): incremental Ouster Rev8 production-ramp updates the 2026-06-15 announcement carried no financial terms, so any unit-volume or revenue disclosure would be the first hard read on the second leg. _(passed 34d ago)_

What Would Change Our Mind

  • A weekly close below $84 would lose the $88–89 breakout pivot that should now act as support and signal a failed breakout, negating the new-high leg.
  • Q2 CY2026 revenue printing below the $700M guide floor on 2026-08-05 would break the AC&C/lidar acceleration story regardless of where price sits.
  • The AI-datacenter-cooling theme flipping to saturated cooling-program cancellations, a hyperscaler capex pause, or peer EMS names losing AI-cooling revenue would remove the primary demand leg.
  • A confirmed loss of a major AC&C program or a rupture in the Ouster relationship would collapse the two-buildout thesis.

Correlation Notes

BHE trades as a second-derivative play on hyperscaler AI capex and datacenter thermal spend, correlating with liquid-cooling peers (Vertiv, nVent, CoolIT/Ecolab) and the broader AI-datacenter-infrastructure complex, and via the Ouster leg with the lidar/autonomy sensing cohort (Ouster itself, plus robotics/physical-AI names). As an EMS contract manufacturer, revenue is sensitive to semi-cap and industrial capex cycles, so a broad slowdown in datacenter build-outs or industrial orders would pressure the name faster than a ~1.3% net margin can absorb. Idiosyncratic risk: single-program and single-customer concentration in AC&C means the stock can decouple from the theme on a program-specific headline in either direction.

Notes

  • Q1 CY2026 reported 2026-04-29: rev $677.3M (+7.2% YoY), non-GAAP EPS $0.58 (+4.8% vs cons), GAAP EPS $0.36; stock +13.9% on print, +21.5% cumulative by 2026-05-02.
  • Q2 CY2026 guide: rev $700-740M, non-GAAP EPS $0.65-0.71. FY26 rev growth raised to 9-10% from mid-single-digits.
  • Segment growth Q1 CY2026: AC&C +41% YoY (AI/HPC cooling), Medical +24% YoY. Op profit +86%, net income +257% YoY.
  • Earnings blackout reminder: next print est ~2026-07-28 do NOT initiate fresh size within 3 trading days of it.
  • Price ~$84 (2026-06-01) is ABOVE the $78 avg analyst PT; 52wk range $34.44-$89.40, mcap ~$3.03B. Stretched-above-MA chase risk prefer 20-wk EMA pullback (~$72) for entry.
  • Archetype: picks & shovels, NOT a6 retail squeeze move is fundamentally driven, no tight 1% cap needed.
  • EARNINGS DATE CORRECTED: next print is Q2 CY2026 on 2026-08-05 (prior dossier estimated ~2026-07-28 — wrong). Do NOT initiate fresh size within 3 trading days of it.
  • Q1 CY2026 reported 2026-04-29: rev $677.3M (+7.2% YoY), non-GAAP EPS $0.58 (+4.8% vs cons), GAAP EPS $0.36; +13.9% on print.
  • Q2 CY2026 guide (2026-04-29): rev $700-740M, non-GAAP EPS $0.65-0.71. FY26 rev growth raised to 9-10% from mid-single-digit.
  • Segment growth Q1 CY2026: AC&C +41% YoY (AI/HPC liquid cooling), Medical +24% YoY. Op profit +86%, net income +257% YoY. Op cash flow $47M (+49%), FCF ~$29M, CCC 67d from 86d. Gross margin ~10.2%.
  • 2026-06-05: rejected -5.21% to $83.92 from $88.53 after tagging ~$88.5 near the $89.40 52wk high first visible distribution day; structure MATURING, prefer pullback to ~$72 20-wk EMA for entry.
  • Post-print PT raises (~2026-04-30): Lake Street $92 from $62, Needham $80 from $62, both Buy. Avg PT $78 (price above it), high $92, low $62. Simply Wall St fair value ~$60.
  • Archetype: picks & shovels, NOT a6 retail squeeze move is fundamentally driven by AI-cooling + semi-cap, no tight 1% cap needed.
  • TTM P/E ~89, forward P/E ~29 on guided ramp; ~35.9M shares, mcap ~$3.01B. Valuation rich on trailing basis guide wobble compresses multiple fast.
  • 2026-06-15: Ouster + Benchmark expanded partnership to scale HIGH-VOLUME production of new Rev8 digital-lidar OS sensor family. Benchmark does complex microelectronics + automated optical assembly across 20 facilities/8 countries; capacity >100,000 units/yr; planned 10-year production life; markets = industrial/robotics/automotive/smart-infra. No financial terms disclosed. This is a SECOND secular leg (autonomy/robotics) on top of AI-cooling.
  • STRUCTURE CHANGE vs prior dossier: the expected pullback to the ~$72 20-week EMA never came. BHE based above its prior $88–89 ceiling and broke out to a NEW all-time high. 2026-06-21 ~$92.17 (prev close $91.05, intraday $91.15–$94.75); 52wk range now $34.44–$94.75 (high was $89.40). The 2026-06-05 −5.21% rejection did NOT roll over it consolidated and broke higher on the Ouster catalyst.
  • Performance as of 2026-06-15: YTD +104.9%, 12-month +248%, 30-day +5.9%. Net margin ~1.3% (down from ~1.9% YoY) thin EMS economics. Significant insider selling flagged over past 3 months.
  • Valuation: ~$92 sits ~18% above the $78 avg analyst PT (high $92, low $62). Simply Wall St ~196% above fair value. TTM P/E high-80s, forward ~29 on guided ramp. ~35.9M shares, mcap ~$3.3B.
  • EARNINGS BLACKOUT: next print is Q2 CY2026 on 2026-08-05 (outside the 30-day window). Guide $700–740M rev / $0.65–0.71 non-GAAP EPS, FY26 growth raised to 9–10%. Do NOT initiate fresh size within 3 trading days of it.
  • Q1 CY2026 (reported 2026-04-29): rev $677.3M (+7.2% YoY), non-GAAP EPS $0.58 (+4.8% vs cons), GAAP EPS $0.36. AC&C +41% YoY, Medical +24% YoY. Op profit +86%, net income +257% YoY, op cash flow $47M (+49%), FCF ~$29M, CCC 67d from 86d, gross margin ~10.2%. Stock +13.9% on print. Post-print PT raises: Lake Street $92 (from $62), Needham $80 (from $62), both Buy.
  • Archetype: picks & shovels (arms-dealer), NOT a thin-float retail squeeze move is fundamentally driven by AI-cooling + semi-cap + now lidar/robotics. No tight per-name cap needed; the discipline is entry timing, not position fragility.
  • Dividend: $0.17/quarter ($0.68 annualized, ~0.74% yield) minor, not a trade driver.
  • Earnings blackout reminder: Q2 CY2026 print is 2026-08-05 (~25 days out as of 2026-07-11). Avoid fresh size within 3 trading days (~2026-07-31 onward) the thesis is not earnings-driven, so the print is binary risk to sidestep, not to chase.
  • Q1 CY2026 reported 2026-04-29: rev $677.3M (+7.2% YoY), non-GAAP EPS $0.58 (+4.8% vs cons), GAAP EPS $0.36; +13.9% on print. AC&C +41% YoY, Medical +24% YoY. Op profit +86%, net income +257% YoY, op cash flow $47M (+49%), FCF ~$29M, CCC 67d from 86d, gross margin ~10.2%.
  • Q2 CY2026 guide (2026-04-29): rev $700–740M, non-GAAP EPS $0.65–0.71. FY26 rev growth raised to 9–10% from mid-single-digit.
  • Ouster Rev8 expansion announced 2026-06-15: >100,000 units/yr across 20 facilities in 8 countries, 10-year production life; no financial terms disclosed. First hard read on this leg is any unit/revenue disclosure, likely on the 2026-08-05 call.
  • Insider selling flagged across the prior 3 months (as of 2026-06-15) into strength distribution signal while momentum chases.
  • Structure: broke to fresh ATH ~$94.75 on the 2026-06-15 catalyst after basing above the $88–89 ceiling; −5.2% distribution day 2026-06-05 near $88.5 did not roll over. 52wk range $34.44–$94.75, ~35.9M shares, mcap ~$3.0B.
  • Stretched-above-MA chase risk prefer a $88–89 breakout-shelf retest or ~$72 20-wk EMA reset for a cleaner fresh entry rather than the all-time high.
  • Archetype: picks & shovels, fundamentally driven (AI-cooling + semi-cap + lidar/autonomy), not a retail squeeze no tight 1%/name cap needed.
  • Valuation: TTM P/E ~89, forward ~29 on the guided ramp; net margin thin ~1.3% (down from ~1.9% YoY). Multiple hinges on the ramp compounding.
  • No new price/news/filings supplied for this 2026-07-11 refresh structure read carries the ~$92 last-observed level forward; re-validate price on next pass.

Related · shared themes

MRCY

Mercury Systems Inc

Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But the stock just reversed ~16% off its $128.45 ATH; the ~2026-08-10 Q4/full-year print is the next binary.

MEDIUM

OKTA

Okta, Inc.

Identity-security re-rating entering a second, sell-side-led leg: a post-print upgrade wave (KeyBanc street-high $175 on 07-10, Scotiabank upgrade to $165 on 07-06) is still building six weeks after the 05-29 beat-and-raise, lifting the top target 17% in a month. Theme ACCELERATING; the risk is extension and hot retail into a digested 52-week-high gap.

MEDIUM

SNX

TD SYNNEX Corporation

Q2 blowout (rev $19.575B vs $16.8B est, 6/25) broke the seasonal guide-down bear case and the sell-side is chasing higher (MS $374, UBS $352). The channel re-rating is now confirmed by fundamentals, but the catalyst is spent and the next binary is ~3 months out current levels chase the post-earnings gap rather than buy the setup.

MEDIUM

XMTR

Xometry, Inc.

AI-native manufacturing marketplace re-rating on a profitability inflection Q1 marketplace revenue +40% YoY, FY guide raised, Siemens embed plus ~$50M stock buy. Wedbush 7/16 Outperform $126 reopens Street upside above spot after June's above-cluster trade; the ~2026-08-06 Q2 print is the next binary.

MEDIUM

See also · stocks to watch

semiconductor equipment stocks to watch